PDF herunterladen
Semin Neurol 2010; 30(4): 337-349
DOI: 10.1055/s-0030-1267277
© Thieme Medical Publishers

Laboratory Evaluation of Peripheral Neuropathy

Mengjing Chloe Huan1
  • 1Department of Neurology, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
12. Oktober 2010 (online)

    Lizenzen und Reprints

ABSTRACT

Laboratory testing to help determine the cause of a peripheral neuropathy can be challenging. A rational approach, as opposed to a shotgun approach, is advocated for efficiency and expense. The author reviews a spectrum of tests and provides a basis for when to order and not to order.

KEYWORDS

Neuropathy - laboratory testing

REFERENCES

  • 1 Martyn C N, Hughes R AC. Epidemiology of peripheral neuropathy.  J Neurol Neurosurg Psychiatry. 1997;  62(4) 310-318
    CrossrefPubMedGoogle Scholar
  • 2 Dyck P J, Oviatt K F, Lambert E H. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis.  Ann Neurol. 1981;  10(3) 222-226
    CrossrefPubMedGoogle Scholar
  • 3 Barohn R J. Approach to peripheral neuropathy and neuronopathy.  Semin Neurol. 1998;  18(1) 7-18
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 4 England J D, Gronseth G S, Franklin G et al.. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation.  Neurology. 2009;  72(2) 185-192
    CrossrefPubMedGoogle Scholar
  • 5 Smith A G, Singleton J R. The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy.  Arch Intern Med. 2004;  164(9) 1021-1025
    CrossrefPubMedGoogle Scholar
  • 6 Smith A G, Rose K, Singleton J R. Idiopathic neuropathy patients are at high risk for metabolic syndrome.  J Neurol Sci. 2008;  273(1-2) 25-28
    CrossrefPubMedGoogle Scholar
  • 7 Nemni R, Bottacchi E, Fazio R et al.. Polyneuropathy in hypothyroidism: clinical, electrophysiological and morphological findings in four cases.  J Neurol Neurosurg Psychiatry. 1987;  50(11) 1454-1460
    CrossrefPubMedGoogle Scholar
  • 8 Rao S N, Katiyar B C, Nair K R, Misra S. Neuromuscular status in hypothyroidism.  Acta Neurol Scand. 1980;  61(3) 067-177
    CrossrefPubMedGoogle Scholar
  • 9 Duyff R F, Van den Bosch J, Laman D M, van Loon B JP, Linssen W HJ. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study.  J Neurol Neurosurg Psychiatry. 2000;  68(6) 750-755
    CrossrefPubMedGoogle Scholar
  • 10 Kececi H, Degirmenci Y. Hormone replacement therapy in hypothyroidism and nerve conduction study.  Neurophysiol Clin. 2006;  36(2) 79-83
    CrossrefPubMedGoogle Scholar
  • 11 Penza P, Lombardi R, Camozzi F, Ciano C, Lauria G. Painful neuropathy in subclinical hypothyroidism: clinical and neuropathological recovery after hormone replacement therapy.  Neurol Sci. 2009;  30(2) 149-151
    CrossrefPubMedGoogle Scholar
  • 12 Lubec D, Müllbacher W, Finsterer J, Mamoli B. Diagnostic work-up in peripheral neuropathy: an analysis of 171 cases.  Postgrad Med J. 1999;  75(890) 723-727
    CrossrefPubMedGoogle Scholar
  • 13 Burn D J, Bates D. Neurology and the kidney.  J Neurol Neurosurg Psychiatry. 1998;  65(6) 810-821
    CrossrefPubMedGoogle Scholar
  • 14 Brouns R, De Deyn P P. Neurological complications in renal failure: a review.  Clin Neurol Neurosurg. 2004;  107(1) 1-06
    CrossrefPubMedGoogle Scholar
  • 15 Manzoor M, Runcie J. Folate-responsive neuropathy: report of 10 cases.  BMJ. 1976;  1(6019) 1176-1178
    CrossrefPubMedGoogle Scholar
  • 16 Kumar N. Neurological manifestations of systemic disease.  CONTINUUM: Lifelong Learning in Neurology. 2008;  14(1) 13-52
    PubMedGoogle Scholar
  • 17 Schaumburg H, Kaplan J, Windebank A et al.. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome.  N Engl J Med. 1983;  309(8) 445-448
    CrossrefPubMedGoogle Scholar
  • 18 Berger A, Schaumburg H H. More on neuropathy from pyridoxine abuse.  N Engl J Med. 1984;  311(15) 986-987
    PubMedGoogle Scholar
  • 19 Parry G J, Bredesen D E. Sensory neuropathy with low-dose pyridoxine.  Neurology. 1985;  35(10) 1466-1468
    PubMedGoogle Scholar
  • 20 Bernstein A L. Vitamin B6 in clinical neurology.  Ann N Y Acad Sci. 1990;  585 250-260
    CrossrefPubMedGoogle Scholar
  • 21 Kumar N, Gross Jr J B, Ahlskog J E. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration.  Neurology. 2004;  63(1) 33-39
    CrossrefPubMedGoogle Scholar
  • 22 Nations S P, Boyer P J, Love L A et al.. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease.  Neurology. 2008;  71(9) 639-643
    CrossrefPubMedGoogle Scholar
  • 23 Rowin J, Lewis S L. Copper deficiency myeloneuropathy and pancytopenia secondary to overuse of zinc supplementation.  J Neurol Neurosurg Psychiatry. 2005;  76(5) 750-751
    CrossrefPubMedGoogle Scholar
  • 24 Lewis S L. Neurological complications of Sjogren syndrome and rheumatoid arthritis.  CONTINUUM: Lifelong Learning in Neurology. 2008;  14(1) 120-144
    PubMedGoogle Scholar
  • 25 Mori K, Iijima M, Koike H et al.. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy.  Brain. 2005;  128(Pt 11) 2518-2534
    CrossrefPubMedGoogle Scholar
  • 26 Gøransson L G, Herigstad A, Tjensvoll A B, Harboe E, Mellgren S I, Omdal R. Peripheral neuropathy in primary Sjogren syndrome: a population-based study.  Arch Neurol. 2006;  63(11) 0612-0615
    PubMedGoogle Scholar
  • 27 Said G, Lacroix C. Primary and secondary vasculitic neuropathy.  J Neurol. 2005;  252(6) 633-641
    CrossrefPubMedGoogle Scholar
  • 28 Pagnoux C, Guillevin L. Peripheral neuropathy in systemic vasculitides.  Curr Opin Rheumatol. 2005;  17(1) 41-48
    CrossrefPubMedGoogle Scholar
  • 29 Bouche P, Léger J M, Travers M A, Cathala H P, Castaigne P. Peripheral neuropathy in systemic vasculitis: clinical and electrophysiologic study of 22 patients.  Neurology. 1986;  36(12) 1598-0602
    PubMedGoogle Scholar
  • 30 Castaigne P, Brunet P, Hauw J J, Léger J M, Gherardi R, Guillevin L. [Peripheral nervous system and panarteritis nodosa. Review of 27 cases].  Rev Neurol (Paris). 1984;  140(5) 343-352
    PubMedGoogle Scholar
  • 31 Said G. Necrotizing peripheral nerve vasculitis.  Neurol Clin. 1997;  15(4) 835-848
    CrossrefPubMedGoogle Scholar
  • 32 Chin R L, Sander H W, Brannagan T H et al.. Celiac neuropathy.  Neurology. 2003;  60(10) 1581-1585
    CrossrefPubMedGoogle Scholar
  • 33 Rosenberg N R, Vermeulen M. Should coeliac disease be considered in the work up of patients with chronic peripheral neuropathy?.  J Neurol Neurosurg Psychiatry. 2005;  76(10) 1415-1419
    CrossrefPubMedGoogle Scholar
  • 34 Brannagan III T H, Hays A P, Chin S S et al.. Small-fiber neuropathy/neuronopathy associated with celiac disease: skin biopsy findings.  Arch Neurol. 2005;  62(10) 1574-1578
    CrossrefPubMedGoogle Scholar
  • 35 Rudnicki S A, Dalmau J. Paraneoplastic syndromes of the peripheral nerves.  Curr Opin Neurol. 2005;  18(5) 598-603
    CrossrefPubMedGoogle Scholar
  • 36 Antoine J C, Honnorat J, Camdessanché J P et al.. Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy.  Ann Neurol. 2001;  49(2) 214-221
    CrossrefPubMedGoogle Scholar
  • 37 Kelly J J, Kyle R A, O'Brien P C, Dyke P J. Prevalence of monoclonal protein in peripheral neuropathy.  Neurology. 1981;  31 1480-1483
    PubMedGoogle Scholar
  • 38 Kahn S N, Bina M. Sensitivity of immunofixation electrophoresis for detecting IgM paraproteins in serum.  Clin Chem. 1988;  34(8) 0633-0635
    PubMedGoogle Scholar
  • 39 Kyle R A, Therneau T M, Rajkumar S V et al.. Prevalence of monoclonal gammopathy of undetermined significance.  N Engl J Med. 2006;  354(13) 1362-1369
    CrossrefPubMedGoogle Scholar
  • 40 Kyle R A, Therneau T M, Rajkumar S V et al.. A long-term study of prognosis in monoclonal gammopathy of undetermined significance.  N Engl J Med. 2002;  346(8) 564-569
    CrossrefPubMedGoogle Scholar
  • 41 Dispenzieri A, Kyle R, Merlini G et al.. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.  Leukemia. 2009;  23 215-224
    CrossrefPubMedGoogle Scholar
  • 42 Ramchandren S, Lewis R A. Monoclonal gammopathy and neuropathy.  Curr Opin Neurol. 2009;  22(5) 480-485
    CrossrefPubMedGoogle Scholar
  • 43 Simmons Z, Blaivas M, Aguilera A J, Feldman E L, Bromberg M B, Towfighi J. Low diagnostic yield of sural nerve biopsy in patients with peripheral neuropathy and primary amyloidosis.  J Neurol Sci. 1993;  120(1) 60-63
    CrossrefPubMedGoogle Scholar
  • 44 Kelly Jr J J, Kyle R A, Miles J M, Dyck P J. Osteosclerotic myeloma and peripheral neuropathy.  Neurology. 1983;  33(2) 202-210
    PubMedGoogle Scholar
  • 45 Latov N, Sherman W H, Nemni R et al.. Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin.  N Engl J Med. 1980;  303(11) 618-621
    CrossrefPubMedGoogle Scholar
  • 46 Kissel J T. Autoantibody testing in the evaluation of peripheral neuropathy.  Semin Neurol. 1998;  18(1) 83-94
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 47 Pestronk A, Li F, Griffin J et al.. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein.  Neurology. 1991;  41(3) 357-362
    PubMedGoogle Scholar
  • 48 Kornberg A J, Pestronk A. Antibody-associated polyneuropathy syndromes: principles and treatment.  Semin Neurol. 2003;  23(2) 181-190
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 49 Notermans N C, Wokke J HJ, van den Berg L H et al.. Chronic idiopathic axonal polyneuropathy. Comparison of patients with and without monoclonal gammopathy.  Brain. 1996;  119(Pt 2) 421-427
    CrossrefPubMedGoogle Scholar
  • 50 Wolfe G I, El-Feky W H, Katz J S, Bryan W W, Wians Jr F H, Barohn R J. Antibody panels in idiopathic polyneuropathy and motor neuron disease.  Muscle Nerve. 1997;  20(10) 1275-1283
    CrossrefPubMedGoogle Scholar
  • 51 Periquet I, Kissel J, Collins M et al.. A prospective study of painful sensory neuropathies.  Neurology. 1997;  48 A186-A187
    PubMedGoogle Scholar
  • 52 Pestronk A, Choksi R, Bieser K et al.. Treatable gait disorder and polyneuropathy associated with high titer serum IgM binding to antigens that copurify with myelin-associated glycoprotein.  Muscle Nerve. 1994;  17(11) 1293-1300
    CrossrefPubMedGoogle Scholar
  • 53 Donofrio P D, Wilbourn A J, Albers J W, Rogers L, Salanga V, Greenberg H S. Acute arsenic intoxication presenting as Guillain-Barré-like syndrome.  Muscle Nerve. 1987;  10(2) 114-120
    CrossrefPubMedGoogle Scholar
  • 54 Nemni R, Sanvito L, Quattrini A, Santuccio G, Camerlingo M, Canal N. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia.  J Neurol Neurosurg Psychiatry. 2003;  74(9) 1267-1271
    CrossrefPubMedGoogle Scholar
  • 55 Verma A, Bradley W G. HIV-1 associated neuropathies.  CNS Spectr. 2000;  5(5) 66-72
    PubMedGoogle Scholar
  • 56 Said G, Lacroix C, Planté-Bordeneuve V et al.. Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients.  Brain. 2002;  125(Pt 2) 264-275
    CrossrefPubMedGoogle Scholar

Mark B BrombergM.D. Ph.D. 

Department of Neurology, Clinical Neurosciences Center, University of Utah

175 North Medical Drive, Salt Lake City, UT 84132

eMail: mbromberg@hsc.utah.edu

      >